Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo To Enter Generic Rx Drug Market With OTC Experience In Mind

This article was originally published in The Tan Sheet

Executive Summary

Perrigo plans to complement its OTC pharmaceutical drug business with a foray into generic prescription drugs next year
Advertisement

Related Content

Perrigo Moves In On Major Generic Firms With Agis Acquisition
Perrigo Moves In On Major Generic Firms With Agis Acquisition
Perrigo Moves In On Major Generic Firms With Agis Acquisition
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo’s Generic Loratadine Offerings Could Boost Firm’s Cough/Cold Sales
Perrigo Nets Former Pharmacia Counsel Kingma To Support New Strategy
Perrigo New Products Include Branded Weight-Loss Supplement, Kid’s Multi
Bristol’s “Underperforming” Mead Johnson, OTCs Could Be Shown The Door
Bristol’s “Underperforming” Mead Johnson, OTCs Could Be Shown The Door

Topics

Advertisement
UsernamePublicRestriction

Register

PS095823

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel